Today: 5 June 2026
C3.ai CEO Buys $69 Million Stake, Street Remains Skeptical

C3.ai CEO Buys $69 Million Stake, Street Remains Skeptical

NEW YORK, June 5, 2026, 09:04 EDT

C3.ai founder and CEO Thomas Siebel spent almost $69 million buying 6.17 million Class A shares at $11.16 a share as the company tries to restart growth after another steep revenue drop. The SEC filing comes as C3.ai announced that Shell is expanding its worldwide use of the company’s reliability software.

C3.ai is looking to bring investors back after a tough year with sales trouble, layoffs, and executive turnover. Back in February, Reuters said C3.ai cut 26% of its global workforce under then-CEO Stephen Ehikian as it tried to cut costs following weak performance and a softer-than-expected forecast.

C3.ai posted a fiscal fourth-quarter revenue drop to $51.6 million from $108.7 million last year. Net loss widened to $115.6 million, or 79 cents per share. For the full year, revenue fell to $250.3 million, down from $389.1 million in fiscal 2025.

C3 AI guided fiscal 2027 revenue to a range of $210 million to $240 million, with a projected non-GAAP operating loss of $128 million to $160 million. The company uses non-GAAP numbers to back out certain items, like restructuring charges and stock-based pay. CEO Siebel called the company’s recent sales “entirely unacceptable” and said, “We are here to fix it.” C3 AI

Siebel’s stock move isn’t just a regular open-market buy. The Form 4 showed he exercised a fully vested option for 6,166,667 shares at $11.16, sold 17,350 shares at a weighted-average price of $11.32 to cover RSU tax withholding, and recorded gifts totaling 12.36 million shares.

Shell’s new agreement with C3.ai simplifies C3.ai’s business story. Shell has used C3.ai since 2018 for predictive maintenance to spot equipment problems early. The companies’ expanded multi-year deal now covers over 13,000 machines and brings in agentic AI, adding software agents that spot issues and offer fixes.

C3.ai president Stephen Ehikian said the Shell project proved enterprise AI can run globally and deliver “hundreds of millions of dollars in economic value.” Microsoft’s Sandy Gupta said the Shell rollout on Azure showed “real applications, running in production”—a public boost for Microsoft as it looks to move beyond AI talk and into real customer deals. C3 AI

UBS lifted its price target on C3.ai to $12 from $9 and kept its Neutral call. The firm said the fiscal 2027 revenue outlook was better than what investors were expecting at the midpoint, but warned the year could be “noisy” given restructuring moves, go-to-market changes, and Siebel coming back as CEO. Investing.com

Analysts are divided. Dan Ives at Wedbush kept his Outperform and $15 price target, saying the restructuring is “largely behind it.” DA Davidson’s Lucky Schreiner stayed Underperform, holding to a $7 target and saying Siebel’s buying was meant to “convey confidence” about what’s next. Benzinga

Canaccord Genuity lifted its price target on C3.ai to $10 from $8 and kept its Hold call. The move comes as the firm pointed to lower costs and a drop in headcount to about 700 from around 1,075. Canaccord said issues with C3.ai’s sales execution look fixable, calling it a thesis at this point, not something proven yet.

C3.ai shares were indicated at $10.58 before the U.S. open, off 1.3% from the last close, putting its market cap near $1.5 billion. The stock is still trading well below where it stood during earlier AI rallies.

The competition is tough. Microsoft is already in the Shell rollout with Azure. Palantir says its software runs AI decisions for government and business clients. Palantir’s market cap stood near $364 billion, showing what investors are paying up for in enterprise AI bets.

Risks are still front and center. C3.ai said results could fall short if it runs into issues like ongoing losses, customer concentration, long sales cycles, holding on to execs, or if its reorganized sales and services teams don’t hit the right productivity. The immediate hurdle: halt the revenue decline and prove the revamped salesforce actually brings in deals.

Stock Market Today

  • Aquis Stock Exchange Weekly Highlights: Key Partnerships, Acquisitions, and Leadership Changes
    June 5, 2026, 9:19 AM EDT. The Aquis Stock Exchange saw significant corporate developments this week. ProBiotix Health (PBX) announced a partnership with Slovakia's iProbio to supply a patented probiotic strain for a cardiometabolic supplement. Delta Gold Technologies (DGQ) expanded its intellectual property portfolio with three patent applications from Penn State, also listing its shares on the Frankfurt Exchange. Sulnox Group (SNOX) secured a distribution deal in France, boosting its market reach. Vaultz Capital (V3TC) raised £1m via share subscription. Sterling Digital (ASIC) and Tomahawk Metals (TMHK) advanced energy and mining projects respectively. Incanthera (INC) acquired a Swiss skincare brand and appointed a new CEO, Stuart Robertson. BWA Group (BWAP) named Peter Taylor as CEO, marking key leadership shifts across the exchange.

Latest articles

C3.ai CEO Buys $69 Million Stake, Street Remains Skeptical

C3.ai CEO Buys $69 Million Stake, Street Remains Skeptical

5 June 2026
C3.ai CEO Thomas Siebel invested nearly $69 million to reset the company after revenue plunged to $51.6 million in Q4 and a net loss hit $115.6 million; despite an expanded Shell contract, C3.ai forecasts more losses in fiscal 2027 and warns results could miss expectations due to ongoing restructuring and sales challenges.
Celsius Stock Drops With Investors Eyeing Texas Alani Nu Probe

Celsius Stock Drops With Investors Eyeing Texas Alani Nu Probe

5 June 2026
Celsius shares rebounded 2% premarket to $28.31 after plunging 7.5% on news Texas is investigating whether Celsius and Alani Nu misled consumers about energy drink safety for teens and children—a risk for Alani Nu, which drove $368.1 million of Q1 sales and is key to Celsius’ growth, even as analysts at BofA and Morgan Stanley reiterated bullish views.
Reddit Moves Higher Ahead of Open After $260 Wall Street Target

Reddit Moves Higher Ahead of Open After $260 Wall Street Target

5 June 2026
Reddit shares jumped premarket after Loop Capital reaffirmed a Buy rating and $260 target, implying over 50% upside, as investors focus on surging revenue, advertiser growth, and AI data licensing; bullish call-option activity spiked, but risks remain if ad momentum slows or growth valuations falter, with Q2 guidance leaving little margin for error after the stock’s sharp rally.
SmartKem Moves Higher Premarket as Volume Picks Up in Thinly Traded Nasdaq Listing

SmartKem Moves Higher Premarket as Volume Picks Up in Thinly Traded Nasdaq Listing

5 June 2026
SmartKem surged nearly 80% to $0.5753 in premarket trading Friday after closing up 11.5% at $0.3200, despite no new company news; the sub-$1 price keeps Nasdaq listing compliance and a possible reverse split in focus as shareholders prepare to vote June 23 on capital-structure changes, with the company warning of potential dilution and insufficient cash to fund operations for 12 months.
Bio Green Med Stock Nearly Triples Premarket As Future NRG Deal Could Leave Current Holders Below 1%
Previous Story

Bio Green Med Stock Nearly Triples Premarket As Future NRG Deal Could Leave Current Holders Below 1%

Go toTop